{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:56:14Z","timestamp":1790711774322,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Targeted support for high starting landmark achiecements of Zhejiang Chinese medical unversity","award":["GQD24SH48"],"award-info":[{"award-number":["GQD24SH48"]}]},{"name":"Targeted support for high starting landmark achiecements of Zhejiang Chinese medical unversity","award":["GQD24SH47"],"award-info":[{"award-number":["GQD24SH47"]}]},{"name":"Postgraduate scientific research fund project of Zhejiang Chinese medical university","award":["2024YKJ0 4"],"award-info":[{"award-number":["2024YKJ0 4"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M752912"],"award-info":[{"award-number":["2024M752912"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374102"],"award-info":[{"award-number":["82374102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2025C02174"],"award-info":[{"award-number":["2025C02174"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The China postdoctoral science foundation 75th cohort of upper level grants"},{"name":"The leading talents +X Program of Zhejiang Province"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.phymed.2025.156992","type":"journal-article","created":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T10:16:11Z","timestamp":1750587371000},"page":"156992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Alisol B ameliorated metabolic dysfunction-associated steatotic liver disease via regulating purine metabolism and restoring the gut microbiota disorders"],"prefix":"10.1016","volume":"145","author":[{"given":"Lin","family":"Yiyou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Congcong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1196-715X","authenticated-orcid":false,"given":"Ren","family":"Guilin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Jiannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Yilong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Fucai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Qingsheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2979-9608","authenticated-orcid":false,"given":"Yu","family":"Zhiling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2465-3079","authenticated-orcid":false,"given":"Dou","family":"Xiaobing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2025.156992_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108391","article-title":"PPAR-\u03b3 signaling in nonalcoholic fatty liver disease: pathogenesis and therapeutic targets","volume":"245","author":"Chen","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2025.156992_bib0002","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2050636","article-title":"Roux-en-Y gastric bypass and sleeve gastrectomy induce substantial and persistent changes in microbial communities and metabolic pathways","volume":"14","author":"Dang","year":"2022","journal-title":"Gut. Microbes"},{"key":"10.1016\/j.phymed.2025.156992_bib0003","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1111\/liv.15967","article-title":"Crosstalk in extrahepatic and hepatic system in NAFLD\/NASH","volume":"44","author":"Duan","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.phymed.2025.156992_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155313","article-title":"Alisol B regulates AMPK\/mTOR\/SREBPs via directly targeting VDAC1 to alleviate hyperlipidemia","volume":"128","author":"Gao","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.156992_bib0005","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2223339","article-title":"Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-plus trial sub analysis","volume":"15","author":"G\u00f3mez-P\u00e9rez","year":"2023","journal-title":"Gut. Microbes"},{"key":"10.1016\/j.phymed.2025.156992_bib0006","doi-asserted-by":"crossref","first-page":"28335","DOI":"10.1074\/jbc.272.45.28335","article-title":"The oxidative half-reaction of xanthine dehydrogenase with NAD; reaction kinetics and steady-state mechanism","volume":"272","author":"Harris","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2025.156992_bib0007","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3350\/cmh.2024.0478","article-title":"USP29 alleviates the progression of MASLD by stabilizing ACSL5 through K48 deubiquitination","volume":"31","author":"Hu","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.phymed.2025.156992_bib0008","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2025.156992_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.751802","article-title":"Role of neutrophils in the pathogenesis of nonalcoholic steatohepatitis","volume":"12","author":"Hwang","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.phymed.2025.156992_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108593","article-title":"Berberine prevents NAFLD and HCC by modulating metabolic disorders","volume":"254","author":"Lin","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2025.156992_bib0011","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00535-022-01909-0","article-title":"Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity","volume":"57","author":"Lin","year":"2022","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.phymed.2025.156992_bib0012","first-page":"956","article-title":"Alisol B blocks the development of HFD-induced obesity by triggering the LKB1-AMPK signaling in subcutaneous adipose tissue","author":"Ling","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2025.156992_bib0013","article-title":"Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease among Chinese children with obesity","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.phymed.2025.156992_bib0014","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000310","article-title":"Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease","volume":"8","author":"Long","year":"2024","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.phymed.2025.156992_bib0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jnutbio.2019.05.015","article-title":"Apigenin ameliorates HFD-induced NAFLD through regulation of the XO\/NLRP3 pathways","volume":"71","author":"Lv","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.phymed.2025.156992_bib0016","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2025.156992_bib0017","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/aps.2016.119","article-title":"Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation","volume":"38","author":"Meng","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2025.156992_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914918","article-title":"Prebiotics and probiotics: therapeutic tools for nonalcoholic fatty liver disease","volume":"24","author":"Mijangos-Trejo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2025.156992_bib0019","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41598-020-57784-3","article-title":"Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice","volume":"10","author":"Nishikawa","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2025.156992_bib0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12020-017-1323-4","article-title":"Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice","volume":"57","author":"Ou","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.phymed.2025.156992_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.141151","article-title":"Metabolic restoration: rhubarb polysaccharides as a shield against non-alcoholic fatty liver disease","volume":"305","author":"Qiu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phymed.2025.156992_bib0022","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13646","article-title":"Composition of gut microbiota and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"25","author":"Su","year":"2024","journal-title":"Obes. Rev."},{"key":"10.1016\/j.phymed.2025.156992_bib0023","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2025.156992_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155776","article-title":"Xiezhuo Tiaozhi formula inhibits macrophage pyroptosis in the non-alcoholic fatty liver disease by targeting the SIRT1 pathway","volume":"131","author":"Tian","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.156992_bib0025","doi-asserted-by":"crossref","first-page":"8644","DOI":"10.1039\/D4FO01059K","article-title":"Improving insulin resistance by sulforaphane via activating the Bacteroides and Lactobacillus SCFAs-GPR-GLP1 signal axis","volume":"15","author":"Tian","year":"2024","journal-title":"Food Funct."},{"key":"10.1016\/j.phymed.2025.156992_bib0026","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2025.156992_bib0027","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jhep.2015.11.022","article-title":"Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism","volume":"64","author":"Wan","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2025.156992_bib0028","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1142\/S0192415X23500301","article-title":"Therapeutic effects of Alisma orientale and its active constituents on cardiovascular disease and obesity","volume":"51","author":"Wu","year":"2023","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.phymed.2025.156992_bib0029","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.nutres.2011.03.013","article-title":"Lipoic acid increases the expression of genes involved in bone formation in mice fed a high-fat diet","volume":"31","author":"Xiao","year":"2011","journal-title":"Nutr. Res."},{"key":"10.1016\/j.phymed.2025.156992_bib0030","first-page":"21","article-title":"Two undescribed protostane triterpenoids from the rhizome of alisma plantago-aquatica","author":"Xinnuo","year":"2024","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.phymed.2025.156992_bib0031","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jhep.2015.01.019","article-title":"Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: one stone hits two birds","volume":"62","author":"Xu","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2025.156992_bib0032","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s40168-023-01709-5","article-title":"Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia","volume":"11","author":"Xu","year":"2023","journal-title":"Microbiome"},{"key":"10.1016\/j.phymed.2025.156992_bib0033","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2025.156992_bib0034","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ueg2.12525","article-title":"Therapeutic management of metabolic dysfunction associated steatotic liver disease. United","volume":"12","author":"Zeng","year":"2024","journal-title":"Eur. Gastroenterol. J."},{"key":"10.1016\/j.phymed.2025.156992_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2024.100018","article-title":"Pharmacological treatment for metabolic dysfunction-associated steatotic liver disease and related disorders: current and emerging therapeutic options","volume":"77","author":"Zhang","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phymed.2025.156992_bib0036","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jhep.2024.08.008","article-title":"Thyroid hormone receptor-beta agonist HSK31679 alleviates MASLD by modulating gut microbial sphingolipids","volume":"82","author":"Zhang","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2025.156992_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/nu14122411","article-title":"Alisol B alleviates hepatocyte lipid accumulation and lipotoxicity via regulating rar\u03b1-ppar\u03b3-CD36 cascade and attenuates non-alcoholic steatohepatitis in mice","volume":"14","author":"Zhao","year":"2022","journal-title":"Nutrients"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325006312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325006312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:32:02Z","timestamp":1778776322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325006312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":37,"alternative-id":["S0944711325006312"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156992","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alisol B ameliorated metabolic dysfunction-associated steatotic liver disease via regulating purine metabolism and restoring the gut microbiota disorders","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156992"}}